Quoin Pharmaceuticals, Ltd. - 存託憑證（普通股）
DE ˙ DB
€3.56 0.00 (0.00%)
2026-06-05
分享價格
SecurityDE:2EB0 / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
InstitutionUBS Group AG
Latest Disclosed Ownership2,512 shares
Latest Disclosed Value $ 16,579
UBS Group AG reports 14,676.47% increase in ownership of 2EB0 / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 2,512 shares of Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock) (DE:2EB0) valued at $12,560 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 17 shares of Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock). The current value of the position is $8,943 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F QUOIN PHARMACEUTICALS SPONSORED ADS 74907L409 2,512 2,495 14,676.47 17 0.0000
2026-01-29 2025-12-31 13F QUOIN PHARMACEUTICALS SPONSORED ADS 74907L409 17 16 1,600.00 0 0.0000
2025-11-13 2025-09-30 13F QUOIN PHARMACEUTICALS SPONSORED ADS 74907L409 1 -129 -99.23 0 -100.00 0.0000
2025-08-14 2025-06-30 13F QUOIN PHARMACEUTICALS SPONSORED ADS 74907L409 130 130 1 0.0000
2021-11-15 2021-09-30 13F CELLECT BIOTECHNOLOGY *W EXP 08/03/202 15116C110 0 -62,507 -100.00 0 -100.00
2021-11-15 2021-09-30 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 0 -8,213 0
2021-08-13 2021-06-30 13F CELLECT BIOTECHNOLOGY *W EXP 08/03/202 15116C110 62,507 59,659 2,094.77 13 1,200.00 0.0000
2021-08-13 2021-06-30 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 8,213 6,309 31 0.0000
2021-05-12 2021-03-31 13F CELLECT BIOTECHNOLOGY *W EXP 08/03/202 15116C110 2,848 -1,402 -32.99 1 0.00 0.0000
2021-05-12 2021-03-31 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 1,904 1,904 6 0.0000
2021-02-11 2020-12-31 13F CELLECT BIOTECHNOLOGY *W EXP 08/03/202 15116C110 4,250 -11,750 -73.44 1 -97.06 0.0000
2020-11-12 2020-09-30 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 16,000 -1,004 -5.90 34 -37.04 0.0000
2020-07-31 2020-06-30 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 17,004 11,300 198.11 54 575.00 0.0000
2020-05-01 2020-03-31 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 5,704 5,457 2,209.31 8 700.00 0.0000
2020-02-14 2019-12-31 13F CELLECT BIOTECHNOLOGY SPONSORD ADS NEW 15116C201 247 -5,322 -95.56 1 -66.67 0.0000
2019-11-14 2019-09-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 5,569 -8,869 -61.43 3 -57.14 0.0000
2019-08-14 2019-06-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 14,438 13,039 932.02 7 600.00 0.0000
2019-05-14 2019-03-31 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 1,399 1,399 1 0.0000
2018-11-14 2018-09-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 0 -1,520 -100.00 0 -100.00
2018-08-14 2018-06-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 1,520 1,520 11 0.0000
2018-02-14 2017-12-31 13F CELLECT BIOTECHNOLOGY *W EXP 08/03/202 15116C110 0 -500 -100.00 0 -100.00
2017-11-14 2017-09-30 13F CELLECT BIOTECHNOLOGY *W EXP 08/03/202 15116C110 500 -1,286 -72.00 1 -92.86 0.0000
2017-11-14 2017-09-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 3,342 1,556 27 0.0000
2017-11-14 2017-06-30 13F/A-1 CELLECT BIOTECHNOLOGY SPON ADS 15116C102 1,786 1,786 14 0.0000
2017-08-14 2017-06-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 1,786 1,786 14
2017-11-14 2017-03-31 13F/A-1 CELLECT BIOTECHNOLOGY SPON ADS 15116C102 0 -1,681 -100.00 0 -100.00
2017-02-14 2016-12-31 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 1,681 1,081 180.17 5 66.67 0.0000
2016-11-14 2016-09-30 13F CELLECT BIOTECHNOLOGY SPON ADS 15116C102 600 600 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.